Wednesday April 21, 2021 0 comments
ENGLEWOOD -- Zynex, Inc. (Nasdaq: ZYXI) announced it hired Donald Gregg as VP of sales and operations of its monitoring solutions division.
Gregg will lead operations, sales, marketing and product development of the division, including the production and launch of the CM-1500 Blood Volume Monitor which was granted 510(k) clearance by the U.S. Food and Drug Administration in 2020.
"I am excited to bring Donald in to run our monitoring solutions division. We continue to build out this division, adding personnel in clinical research and sales and marketing,” said Thomas Sandgaard, Zynex founder and CEO.
“With Donald's background, I am confident we will soon have our technology become the standard-of-care for early detection of internal bleeding in surgical and post-surgical recovery. While the CM-1500 is already in full production, the next generation (CM-1600) is well under way and we hope to apply for FDA clearance for that model soon."
Zynex said Gregg brings a wealth of experience to the company. He previously held leadership roles as Smith Medical's VP and GM of infusion systems and Medtronic's senior director of product, marketing and business development of health informatics and monitoring.
Gregg successfully built a direct sales force, launched and commercialized infusion products, remote patient monitoring and clinical decision support software applications. As the result of innovating new products, executing sales plans and creating strategic distribution and partnership agreements he grew each of these businesses by double-digits.
Gregg holds a Bachelor of Science in Marketing from Metropolitan State University, a Master of Business Administration from the University of Phoenix, executive education in Healthcare and Medical Technology Management from the University of St. Thomas and has been a board advisor for med-tech startups.